TR200003345T2 - Moraxella Catarrhalıs'in bileşikleri - Google Patents

Moraxella Catarrhalıs'in bileşikleri

Info

Publication number
TR200003345T2
TR200003345T2 TR2000/03345T TR200003345T TR200003345T2 TR 200003345 T2 TR200003345 T2 TR 200003345T2 TR 2000/03345 T TR2000/03345 T TR 2000/03345T TR 200003345 T TR200003345 T TR 200003345T TR 200003345 T2 TR200003345 T2 TR 200003345T2
Authority
TR
Turkey
Prior art keywords
compounds
moraxella catarrhalis
production
present
polypeptides
Prior art date
Application number
TR2000/03345T
Other languages
English (en)
Inventor
Thonnard Joelle
Original Assignee
Smithkline Beecham Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biologicals S.A. filed Critical Smithkline Beecham Biologicals S.A.
Publication of TR200003345T2 publication Critical patent/TR200003345T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Mevcut bulus BASB020 polipeptid ve BASB020 polipeptid kodlayan polinükleotid ile bu tip polipeptidlerin rekombinant teknikler ile üretilmesine iliskin yöntemleri önermektedir. Mevcut bulus ayrica bunlarin diyagnostik, profilaktik ve terapötik kullanimlarini konu almaktadir.
TR2000/03345T 1998-05-13 1999-05-07 Moraxella Catarrhalıs'in bileşikleri TR200003345T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810285.8A GB9810285D0 (en) 1998-05-13 1998-05-13 Novel compounds

Publications (1)

Publication Number Publication Date
TR200003345T2 true TR200003345T2 (tr) 2001-03-21

Family

ID=10831997

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03345T TR200003345T2 (tr) 1998-05-13 1999-05-07 Moraxella Catarrhalıs'in bileşikleri

Country Status (23)

Country Link
US (2) US7122197B1 (tr)
EP (1) EP1078064B1 (tr)
JP (1) JP4503175B2 (tr)
KR (1) KR100610448B1 (tr)
CN (3) CN1876679A (tr)
AT (1) ATE303442T1 (tr)
AU (1) AU737196B2 (tr)
BR (1) BR9911773A (tr)
CA (1) CA2328502A1 (tr)
CZ (1) CZ298227B6 (tr)
DE (1) DE69927017T2 (tr)
DK (1) DK1078064T3 (tr)
ES (1) ES2247803T3 (tr)
GB (1) GB9810285D0 (tr)
HK (1) HK1036299A1 (tr)
HU (1) HUP0102853A3 (tr)
IL (2) IL139612A0 (tr)
NO (1) NO330169B1 (tr)
NZ (1) NZ508322A (tr)
PL (1) PL199497B1 (tr)
TR (1) TR200003345T2 (tr)
WO (1) WO1999058684A2 (tr)
ZA (1) ZA200006522B (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
KR101239242B1 (ko) 2002-08-02 2013-03-11 글락소스미스클라인 바이오로지칼즈 에스.에이. 항원 조합물을 포함하는 나이세리아 백신 조성물
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
CN111003884B (zh) * 2019-12-05 2021-12-31 浙江海洋大学 重金属污水处理设备及处理方法
CN114703214A (zh) * 2022-03-03 2022-07-05 南京吉芮康生物科技研究院有限公司 一种抗丢失时空可控表达的新型质粒及其应用
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552146A (en) * 1991-08-15 1996-09-03 Board Of Regents, The University Of Texas System Methods and compositions relating to useful antigens of Moraxella catarrhalis
US5712118A (en) 1993-09-29 1998-01-27 Research Foundation Of State University Of New York Vaccine for branhamella catarrhalis
US6440425B1 (en) 1995-05-01 2002-08-27 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella
US6607731B1 (en) * 1995-09-22 2003-08-19 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6090576A (en) * 1996-03-08 2000-07-18 Connaught Laboratories Limited DNA encoding a transferrin receptor of Moraxella
US7341727B1 (en) * 1996-05-03 2008-03-11 Emergent Product Development Gaithersburg Inc. M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
EP0920513A2 (en) 1996-08-12 1999-06-09 The Board Of Regents, The University Of Texas System DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF MORAXELLA CATARRHALIS
US6673910B1 (en) 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
CA2378687A1 (en) 1999-06-18 2000-12-28 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome

Also Published As

Publication number Publication date
ATE303442T1 (de) 2005-09-15
CN100484956C (zh) 2009-05-06
WO1999058684A3 (en) 2000-02-24
NZ508322A (en) 2002-12-20
NO20005697L (no) 2001-01-10
IL139612A (en) 2007-07-24
CA2328502A1 (en) 1999-11-18
EP1078064A2 (en) 2001-02-28
ES2247803T3 (es) 2006-03-01
HUP0102853A3 (en) 2008-04-28
KR20010043573A (ko) 2001-05-25
KR100610448B1 (ko) 2006-08-09
NO20005697D0 (no) 2000-11-10
BR9911773A (pt) 2002-03-05
CN1727359A (zh) 2006-02-01
AU4142199A (en) 1999-11-29
WO1999058684A2 (en) 1999-11-18
JP2002514425A (ja) 2002-05-21
AU737196B2 (en) 2001-08-09
CN1210401C (zh) 2005-07-13
DE69927017D1 (de) 2005-10-06
JP4503175B2 (ja) 2010-07-14
CN1309706A (zh) 2001-08-22
ZA200006522B (en) 2001-11-29
US20060147462A1 (en) 2006-07-06
DK1078064T3 (da) 2006-01-02
HK1036299A1 (en) 2001-12-28
CN1876679A (zh) 2006-12-13
EP1078064B1 (en) 2005-08-31
GB9810285D0 (en) 1998-07-15
HUP0102853A1 (hu) 2001-11-28
PL199497B1 (pl) 2008-09-30
CZ298227B6 (cs) 2007-07-25
DE69927017T2 (de) 2006-03-16
NO330169B1 (no) 2011-02-28
US7122197B1 (en) 2006-10-17
IL139612A0 (en) 2002-02-10
PL344792A1 (en) 2001-11-19
CZ20004203A3 (en) 2001-05-16

Similar Documents

Publication Publication Date Title
TR200003347T2 (tr) Neisseria meningitidis'denBASB029 polinükleotidleri ve polipeptidler
DE69533556D1 (de) N-terminal modifizierte Polypeptide, und Herstellungsprozess
TR200003345T2 (tr) Moraxella Catarrhalıs'in bileşikleri
DE69928925D1 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
DE3782549D1 (de) Neue polypeptide, ihre herstellung und ihre verwendung.
ATE270332T1 (de) Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
FI943146A0 (fi) Signaalipeptideistä vapaiden stafylokinaasien ilmentyminen
ATE312922T1 (de) Moraxella catarrhalis polynukleotide und polypeptide
BR0008917A (pt) Compostos
DE69935213D1 (de) Basb019 proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen
TR200003608T2 (tr) Moraxella Catarrhalis'e ait BASB027 proteinleri ve genleri.
TR200102745T2 (tr) Yeni bileşikler
DE60043658D1 (de) Basb118 polypeptid und polynukleotid aus moraxella catarrhalis
DE60134253D1 (de) Basb205 polypeptide und dafür kodierende polynukleotide
DE60034463D1 (de) Basb119 polypeptid und polynukleotid aus moraxella catarrhalis
DE60039303D1 (de) Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen
DE60035788D1 (de) Polypeptide aus moraxella (branhamella) catarrhalis
ATE293693T1 (de) Moraxella catarrhalis antigen basb117
ATE311458T1 (de) Basb111 polypeptid und polynukleotid aus moraxella catharralis
ATE274582T1 (de) Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis
ATE293692T1 (de) Moraxella catarrhalis antigen basb120
ATE414155T1 (de) Moraxella (branhamella) catarrhalis polypeptide
ATE515511T1 (de) Nicht-typisierbare haemophilus influenzae basb201 polypeptide und polynukleotide und deren verwendungen